Columbus, OH, United States of America

Margaret Hanausek-Walaszek

This inventor holds 3 USPTO granted patents. Top assignee: The Ohio State University. Active years: 1988-1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Margaret Hanausek-Walaszek. Retrieved from https://idiyas.com/inventor/margaret-hanausek-walaszek-041gn0rt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.5

ph-index = 3

Forward Citations = 30(Granted Patents)


Location History:

  • Columbus, OH (US) (1988 - 1989)
  • Smithville, TX (US) (1990)

Company Filing History:


Years Active: 1988-1990

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Margaret Hanausek-Walaszek

Introduction

Margaret Hanausek-Walaszek is a notable inventor based in Columbus, OH (US). She has made significant contributions to the field of cancer research through her innovative patents. With a total of 3 patents, her work focuses on the detection and testing of cancer-related markers.

Latest Patents

One of her latest patents is titled "Detection of circulating antibodies to a cancer marker protein." This patent describes a method and kit for detecting the presence of cancers and pre-neoplastic cells that produce an oncofetal phosphoprotein. This protein has a molecular weight of approximately 60,000 and is capable of increasing the release of ribonucleic acid from cell nuclei. The method involves detecting auto-antibodies to this oncofetal phosphoprotein in subjects suspected of having cancer or pre-neoplastic cells. The kit includes purified oncofetal phosphoprotein, making it a valuable tool in cancer diagnostics.

Another significant patent is the "Process for testing the carcinogenicity of a material or the presence of." This patent outlines a method for screening materials for carcinogenic properties by administering them to test animals. Biological tissue, preferably plasma, is then assayed for the presence of a 60K cancer-associated phosphoprotein. This test is applicable to a wide range of chemically diverse carcinogens, demonstrating its versatility in cancer research.

Career Highlights

Margaret is affiliated with The Ohio State University, where she continues her research and development in cancer diagnostics. Her work has garnered attention for its potential impact on early cancer detection and treatment.

Collaborations

Margaret has collaborated with notable colleagues such as Thomas E Webb and Dorothy E Schumm. These collaborations have further enriched her research and contributed to the advancement of cancer-related innovations.

Conclusion

Margaret Hanausek-Walaszek's contributions to cancer research through her patents highlight her innovative spirit and dedication to improving diagnostic methods. Her work continues to pave the way for advancements in the field of oncology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…